Hrt Financial LP Viracta Therapeutics, Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.89 - $2.13 $15,388 - $36,829	17,291 New	17,291 $24,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $12.95 $179,886 - $308,546	-23,826 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.58 - $18.67 $180,601 - $444,831	23,826 New	23,826 $220,000

9.39M

5.9K

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $20.3M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.